Manchester, England Mar 19, 2026 (Issuewire.com) - HealthOrbit AI, a clinical artificial intelligence platform designed to eliminate the administrative burden in modern healthcare, has raised significant funds in its ongoing funding round as its live Crowdcube investment campaign continues to attract investor interest. With the campaign closing on 30th March 2026 and an increasing number of investors committed on the platform, the company is targeting a substantial raise to accelerate product development, expand its commercial footprint, and deepen its presence in existing hospital network relationships.
The announcement marks a significant milestone for the UK-based health-tech startup, which has grown from concept to a revenue-generating, multi-country operation in a short period of time. HealthOrbit AI says the fundraise is being driven not by aspiration alone, but by demonstrated demand from healthcare providers actively seeking AI-driven solutions to the documentation and billing challenges that cost them millions in lost productivity and revenue each year.
ABOUT HEALTHORBIT AI
HealthOrbit AI is developing an AI-powered platform that automates clinical documentation, medical coding, billing, and operational workflows. Doctors currently spend a significant portion of their day on administrative tasks, driving burnout and revenue leakage. Using ambient voice technology, HealthOrbit AI captures and processes clinical information in real time, directly within existing systems, without adding to a clinician's workload.
Built with practising clinicians at its core, the platform is designed for real-world usability in high-pressure healthcare environments. HealthOrbit AI is listed on the NHS Ambient Voice Technology (AVT) Registry, a listing that signals regulatory credibility and has been instrumental in opening doors with NHS-connected trusts and hospital networks internationally.
TRACTION & COMMERCIAL MILESTONES
HealthOrbit AI's fundraising is underpinned by a set of commercial milestones that demonstrate the platform's real-world viability. The company is not raising on the promise of future product development alone, it is raising against a backdrop of active customers, recurring revenue, and institutional engagement. Key milestones include:
- Significant funds raised to date across the wider funding round, including contributions ahead of the Crowdcube campaign launch
- Strong recurring revenue from paying customers across multiple countries
- A growing number of investors have committed to Crowdcube since the campaign opened
- NHS AVT Registry, verified and listed on the NHS Ambient Voice Technology Registry
- International pilots active across multiple hospital networks in the UK and internationally
“When we started HealthOrbit AI, we knew the problem was real. Every clinician we spoke to described the same exhaustion, the same hours lost to paperwork, the same frustration that the system was designed around documentation rather than patients. What has surprised us is the speed at which healthcare providers have recognised the value of what we are building. The traction across multiple countries is not a coincidence. It is validation that the market has been waiting for a solution like this.”
— Rakesh Kaipenchery, Co-Founder & CEO, HealthOrbit AI
INVESTOR OPPORTUNITY & USE OF FUNDS
The capital raised through this round will be used to scale HealthOrbit AI's commercial operations, strengthen its engineering team, and accelerate deployment across existing hospital network partnerships. With the infrastructure and regulatory foundation already in place, the company says it is focused on execution, converting active engagements into contracted deployments and expanding its customer base in existing geographies before entering new markets.
The Crowdcube round is eligible for SEIS and EIS tax relief, providing eligible UK investors with substantial tax advantages on their investment:
- SEIS (Seed Enterprise Investment Scheme): Significant income tax relief on the amount invested, plus loss relief and CGT exemption on gains
- EIS (Enterprise Investment Scheme): Meaningful income tax relief on the amount invested, with additional CGT deferral benefits
- Capital Gains Relief: Zero capital gains tax on qualifying returns from either scheme, subject to HMRC approval
These incentives, combined with the company's existing revenue base and institutional traction, make this round an opportunity for investors to back a revenue-generating health-tech business at an early stage, with meaningful downside protection through the SEIS and EIS schemes. Investors are encouraged to seek independent financial advice before committing.
LIVE INVESTOR WEBINAR
To give prospective investors the opportunity to engage directly with the HealthOrbit AI founding team, the company is hosting a live investor Q&A webinar on 24th March Tuesday, 7:00 PM – 7:30 PM GMT. The session will cover the company's product roadmap, commercial pipeline, and plans for the use of funds raised through the Crowdcube campaign. Participants are welcome to submit questions live.
The webinar can be joined at: meet.zoho.in/gcaw-skb-dru
ABOUT THE CROWDCUBE CAMPAIGN
The HealthOrbit AI Crowdcube campaign is live and open for investment. Eligible UK investors can access SEIS and EIS tax relief on qualifying investments. The campaign closes on 30th March 2026, and more details can be found on the HealthOrbit AI Crowdcube campaign.
Capital at risk. Investments in early-stage companies are high risk, and investors could lose their entire investment. Tax relief is subject to individual circumstances and HMRC approval. This is not financial advice. Please seek independent advice. Investment is facilitated via Crowdcube Capital Ltd (FCA No. 650205).
Media Contact
HealthOrbit AI Info@healthorbit.ai +44 1613886008 Suite 212 Oakland House, 76 Talbot Road, Manchester, England, M16 0PQ https://healthorbit.ai/
